Inventor
DAVID E. NICHOLS
Inventor
US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07BGeneral methods of organic chemistry19%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium19%
C07DHeterocyclic compounds15%
C07CAcyclic or carbocyclic compounds5%
PatentTitleYear
12,545,642Pharmaceutically acceptable salts of psilocin and uses thereof202612,459,965Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use202512,447,164Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin202512,433,904Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin202512,398,093Compounds and methods for treating inflammatory disorders202512,377,112Methods of treating neurocognitive disorders, chronic pain and reducing inflammation202512,312,375Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use202511,939,346Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use202411,865,126Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin202411,851,451Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use202311,738,035Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin202311,680,043Pharmaceutically acceptable salts of psilocin and uses thereof202311,629,159Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use202311,564,935Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin202311,505,564Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use202211,447,510Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use202211,312,684Pharmaceutically acceptable salts of psilocin and uses thereof202211,180,517Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use202111,149,044Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to COMPASS PATHFINDER LTD (15)· patent assignee history
2021–2026Based in US· patent location history
2022–2026Patents assigned to ELEUSIS THERAPEUTICS US INC (3)· patent assignee history
2025Patents assigned to UNIV LOUISIANA STATE (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| COMPASS PATHFINDER LTD | 15 | 2021–2025 |
| ELEUSIS THERAPEUTICS US INC | 3 | 2022–2026 |
| UNIV LOUISIANA STATE | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 19 | 2021–2026 |